EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pulmonary vascular disease as a complication of pediatric congenital heart diseases

Julie Wacker, Raphael Joye, Leon Genecand, Frederic Lador, Maurice Beghetti

Translational Pediatrics · 2023-05 · 12 (5) · 1041-1052

DOI: 10.21037/tp-23-64 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Pediatrics, 2023-05. Verfasst von Julie Wacker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology Unit, Department of Pediatrics, Gynecology, and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital and acquired heart diseases can cause pulmonary hypertension (PH) in children, either by increasing pulmonary blood flow (PBF), left atrial pressure (LAp), and/or pulmonary vascular resistance (PVR). Pathophysiological process of pulmonary vascular disease (PVD) in different types of congenital heart diseases (CHDs) are reviewed hereafter. As with other types of PH, a rigorous diagnostic evaluation is mandatory to characterize the etiology of the PH, rule out other or additional causes of PH, and establish a risk profile. Cardiac catheterization remains the gold standard exam for PH diagnosis. Treatment of pulmonary arterial hypertension (PAH) associated with CHD (PAH-CHD) can then be started according to the recent guidelines recommendations, although most of the evidence is extrapolated from studies on other causes of PAH. PH in pediatric heart disease is often multifactorial, and sometimes unclassifiable, making the management of these patients complicated. The operability of patients with a prevalent left-to-right shunt and increase of PVR, the management of children with PH associated with left-sided heart disease, the challenges of pulmonary vascular disorders in children with univentricular heart physiology and the role of vasodilator therapy in failing Fontan patients are some of the hot topics discussed in this review.

Schlagwörter

Stichwörter der Autor:innen

Eisenmenger syndromeFontanPulmonary hypertension (PH)congenital heart disease (CHD)pulmonary vascular disease (PVD)

Autor:innen und Institutionen

  • Pediatric Cardiology Unit, Department of Pediatrics, Gynecology, and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.
  • Pulmonary Hypertension Program, Geneva University Hospitals, Geneva, Switzerland.
  • Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique (CURCCCP), University of Geneva, Geneva, Switzerland.
  • Division of Pulmonary Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.

Zitieren

APA

Wacker, J., Joye, R., Genecand, L., Lador, F., & Beghetti, M. (2023). Pulmonary vascular disease as a complication of pediatric congenital heart diseases. Translational Pediatrics, 12(5), 1041-1052. https://doi.org/10.21037/tp-23-64

Vancouver

Wacker J, Joye R, Genecand L, Lador F, Beghetti M. Pulmonary vascular disease as a complication of pediatric congenital heart diseases. Translational Pediatrics. 2023;12(5):1041-1052. doi:10.21037/tp-23-64

BibTeX
@article{Wacker2023,
  author = {Wacker, Julie and Joye, Raphael and Genecand, Leon and Lador, Frederic and Beghetti, Maurice},
  title = {Pulmonary vascular disease as a complication of pediatric congenital heart diseases},
  journal = {Translational Pediatrics},
  year = {2023},
  volume = {12},
  number = {5},
  pages = {1041--1052},
  doi = {10.21037/tp-23-64}
}
Kostenlos starten →